Search

Your search keyword '"WJ Koh"' showing total 488 results

Search Constraints

Start Over You searched for: Author "WJ Koh" Remove constraint Author: "WJ Koh"
488 results on '"WJ Koh"'

Search Results

1. Characteristics of Singapore lung cancer patients who miss out on lung cancer screening recommendations

6. Pattern Identification in Patients with Functional Dyspepsia Using Brain-Body Bio-Signals: Protocol of a Clinical Trial for AI Algorithm Development.

8. Normative reference values, determinants and regression equations for the incremental shuttle walk test (ISWT) in healthy Asian population aged 21 to 80 years.

9. Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registry.

10. In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, including Macrolide-/Amikacin-Resistant Clinical Isolates.

11. The Value and Process of Inclusion: Using Sensitive, Respectful, and Inclusive Language and Images in NCCN Content.

12. Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma.

13. CBCT Evaluation of Buccolingual Orientation of Inferior Alveolar Canal in Mandibular Posterior Region for Implant Planning.

14. Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement.

16. Impact of Race/Ethnicity on Long Term Outcomes After Percutaneous Coronary Intervention with Drug-Eluting Stents.

17. Extraluminal migration of ingested fish bone in the upper aerodigestive tract: A series of three cases with broad clinical spectrum of manifestations and outcomes.

18. Hoarseness in an older adult: Ortner syndrome.

19. Prostate cancer in multi-ethnic Asian men: Real-world experience in the Malaysia Prostate Cancer (M-CaP) Study.

20. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease.

21. Impact of treatment duration on recurrence of chronic pulmonary aspergillosis.

22. Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease.

23. Outcomes of Inhaled Amikacin-Containing Multidrug Regimens for Mycobacterium abscessus Pulmonary Disease.

24. In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.

25. Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates.

26. Genetic Analysis of Korean Adult Patients with Nontuberculous Mycobacteria Suspected of Primary Ciliary Dyskinesia Using Whole Exome Sequencing.

27. Subspecies-specific sequence detection for differentiation of Mycobacterium abscessus complex.

28. Toward Optimization of Cancer Care in Sub-Saharan Africa: Development of National Comprehensive Cancer Network Harmonized Guidelines for Sub-Saharan Africa.

30. A nonsense variant in NME5 causes human primary ciliary dyskinesia with radial spoke defects.

31. NCCN resource-stratified and harmonized guidelines: A paradigm for optimizing global cancer care.

32. The effect of intravenous magnesium on postoperative morphine consumption in noncardiac surgery: A systematic review and meta-analysis with trial sequential analysis.

33. Diagnostic Performance of the GENEDIA MTB/NTM Detection Kit for Detecting Mycobacterium tuberculosis and Nontuberculous Mycobacteria With Sputum Specimens.

34. Quality Measurement in Cancer Care: A Review and Endorsement of High-Impact Measures and Concepts.

35. miRNA Expression Profiles and Potential as Biomarkers in Nontuberculous Mycobacterial Pulmonary Disease.

36. Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis.

37. Rifabutin Is Active against Mycobacterium abscessus in Mice.

38. Prognostic factors associated with long-term mortality in 1445 patients with nontuberculous mycobacterial pulmonary disease: a 15-year follow-up study.

39. Treatment of Isoniazid-Resistant Pulmonary Tuberculosis.

40. Development of tuberculosis in cancer patients receiving immune checkpoint inhibitors.

41. Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in Mycobacterium abscessus .

42. Nontuberculosis mycobacteria infections: would there be pharmacodynamics without pharmacokinetics?

43. Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea.

44. First Isolation of Mycobacterium virginiense From a Human Pulmonary Specimen.

45. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.

46. Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment.

47. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.

48. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.

49. In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.

50. Same meat, different gravy: ignore the new names of mycobacteria.

Catalog

Books, media, physical & digital resources